$14.32
+2.3%Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
Last Annual Value
11.12M
3-Year CAGR
41%
5-Year CAGR
23%
10-Year CAGR
11%
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Shoulder Innovations, Inc. NYSE:SI | 11.12M | 40.5% | N/A | N/A | |
![]() CVRx, Inc. NASDAQ:CVRX | 8.31M | 9.9% | 18.0% | N/A | |
![]() Lifecore Biomedical, Inc. NASDAQ:LFCR | 88.57M | 5.6% | 7.4% | -15.4% | |
![]() NeoGenomics, Inc. NASDAQ:NEO | 444.79M | 8.6% | 8.4% | 12.8% | |
![]() Quanterix Corporation NASDAQ:QTRX | 73.94M | 15.4% | 10.1% | 22.3% | |
![]() Exagen Inc. NASDAQ:XGN | 27.78M | 6.3% | 6.2% | N/A | |
![]() Enanta Pharmaceuticals, Inc. NASDAQ:ENTA | 4.59M | N/A | N/A | N/A | |
![]() Nautilus Biotechnology, Inc. NASDAQ:NAUT | 6.46M | 4.3% | 17.9% | N/A | |
![]() Aardvark Therapeutics, Inc. Common Stock NASDAQ:AARD | 36.00K | N/A | N/A | N/A | |
![]() Assembly Biosciences, Inc. NASDAQ:ASMB | 129.00K | -86.2% | N/A | 4.9% | |
![]() Outset Medical, Inc. NASDAQ:OM | 72.72M | -10.5% | -5.2% | N/A |
Continue your SI research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.